|
RayBiotech inc
pe cd34 ![]() Pe Cd34, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mouse+anti+human+cd34+monoclonal+antibodies/Mouse+anti-Human%2FRat+CD34+Antibody+%5BPE+Conjugated%5D/10__4103_slash_nrr__nrr___d___24___00129-87-17-18 Average 93 stars, based on 1 article reviews
pe cd34 - by Bioz Stars,
2026-10
93/100 stars
|
Buy from Supplier |
|
Serotech Inc
cd34-fitc clone 1h6 antibody ![]() Cd34 Fitc Clone 1h6 Antibody, supplied by Serotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mouse+anti+human+cd34+monoclonal+antibodies/cd34+mouse+anti+human+antibody/pmc05327053-197-10-14 Average 90 stars, based on 1 article reviews
cd34-fitc clone 1h6 antibody - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
Maxim Biotech Inc
mouse anti-human cd34 monoclonal antibody ![]() Mouse Anti Human Cd34 Monoclonal Antibody, supplied by Maxim Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mouse+anti+human+cd34+monoclonal+antibodies/mouse+anti+human+cd34+monoclonal+antibody/pmc04907216-43-8-30 Average 90 stars, based on 1 article reviews
mouse anti-human cd34 monoclonal antibody - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
Fuzhou Maxim Biotech
mouse anti-human monoclonal cd34 antibody ![]() Mouse Anti Human Monoclonal Cd34 Antibody, supplied by Fuzhou Maxim Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mouse+anti+human+cd34+monoclonal+antibodies/mouse+anti+human+monoclonal+cd34+antibody/pmc05549640-102-5-15 Average 90 stars, based on 1 article reviews
mouse anti-human monoclonal cd34 antibody - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
Tektronix inc
mouse anti-human cd34 class ii monoclonal antibody ![]() Mouse Anti Human Cd34 Class Ii Monoclonal Antibody, supplied by Tektronix inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mouse+anti+human+cd34+monoclonal+antibodies/mouse+anti+human+cd34+class+ii+monoclonal+antibody/pm21161731-27-39-47 Average 90 stars, based on 1 article reviews
mouse anti-human cd34 class ii monoclonal antibody - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
MOUSE ANTI HUMAN CD34 CLASS II:RPE; MOUSE ANTI HUMAN CD34 CLASS II:RPE
|
Buy from Supplier |
|
Mouse anti-Human/Rat CD34 Antibody
|
Buy from Supplier |
|
Mouse anti-Human/Rat CD34 Antibody [PE Conjugated]
|
Buy from Supplier |
|
Mouse anti-Human CD34 Antibody Cocktail [IHC only]
|
Buy from Supplier |
|
Mouse anti-Human CD34 Antibody Cocktail [IHC only]
|
Buy from Supplier |
|
Mouse anti-Human/Rat CD34 Antibody
|
Buy from Supplier |
Image Search Results
Journal: Neural Regeneration Research
Article Title: A vascular endothelial growth factor–loaded chitosanhyaluronic acid hydrogel scaffold enhances the therapeutic effect of adipose-derived stem cells in the context of stroke
doi: 10.4103/nrr.nrr-d-24-00129
Figure Lengend Snippet: Figure 1 |ADSC culture and identity verification, and the effect of VEGF on ADSCs. (A) Representative images of ADSCs on days 3 (i) and 5 (ii) of primary culture, as well as third-passage ADSCs (iii). On day 3, the cells were spindle-shaped, isolated, scattered, and adherent. By day 5, the cells had proliferated rapidly, and the cell colonies had expanded. The morphology of the third-passage cells was uniform, displaying a characteristic fish-like, fibrous, and swirling arrangement. Scale bar: 100 μm. (B) Flow cytometric analysis of CD90, CD29, CD34, and CD45 expression on the cell surface of third-passage ADSCs. (C) CCK-8 analysis of the viability of ADSCs treated with different concentrations of VEGF. Data are expressed as mean ± SEM (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, vs. Cont group (one-way analysis of variance with Bonferroni’s post hoc test). (D) Enzyme-linked immunosorbent assay analysis of VEGF, b-FGF, TGF-β, BDNF, and IGF-1 concentration by ADSC cells treated with VEGF (50 ng/mL) or left untreated. Data are expressed as mean ± SEM (n = 12). **P < 0.01, ***P < 0.001, vs. VEGF- group (one-way analysis of variance with Bonferroni’s post hoc test [C] or unpaired t-test [D]). ADSCs: Adipose-derived mesenchymal stem cells; BDNF: brain-derived neurotrophic factor; b-FGF: basic fibroblast growth factor; Cont: control; IGF- 1: insulin-like growth factor-1; TGF-β: transforming growth factor-β; VEGF: vascular endothelial growth factor.
Article Snippet: The following fluorochrome-labeled antibodies were utilized: APC-cy7-CD45 (BD Biosciences, San Jose, CA, USA, Cat# 561586, RRID: AB_10896305),
Techniques: Isolation, Expressing, CCK-8 Assay, Enzyme-linked Immunosorbent Assay, Concentration Assay, Derivative Assay, Control
Journal: Experimental and Therapeutic Medicine
Article Title: Effect of rapamycin on endometriosis in mice
doi: 10.3892/etm.2016.3280
Figure Lengend Snippet: Representative images of immunohistochemical analysis of CD34 in endometriotic lesions of the (A) control, (B) saline and (C) rapamycin-treated groups. Staining was performed with the streptomycin avidin-peroxidase method. Magnification, ×400.
Article Snippet: Mouse anti-human VEGF (1:200; cat. no. RB-9031) and
Techniques: Immunohistochemical staining, Control, Saline, Staining, Avidin-Biotin Assay
Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Article Title: Relative Computed Tomography (CT) Enhancement Value for the Assessment of Microvascular Architecture in Renal Cell Carcinoma
doi: 10.12659/MSM.902957
Figure Lengend Snippet: CT scan and immunohistochemical staining results (CD34, 200×) of three cases. ( A1, A2 , a 67-year-old woman): Obvious heterogeneous contrast enhancement in the right kidney (bold arrow) with a VTA value of 160 HU and a RTV value of 1.3 was displayed. There were many microvessels which mainly consisted of relatively mature vessels with lumen (bold arrow) and the microvascular areas were the largest. ( B1, B2 , a 44-year-old man): Moderate homogeneous contrast enhancement in the left kidney (curved arrow) with a VTA value of 87 HU and a RTV value of 0.75 was displayed. Microvessels mainly consisted of vessels with fissured lumen (curved arrow) and the microvascular area was large. ( C1, C2 , a 59-year-old man): Mild contrast enhancement (long arrow) with a VTA value of 80 HU and a RTC value of 0.6 was displayed. Pseudo-capsule (short arrow) appeared as hyper density in the lesion margin. There were a few microvessels which involvement in microvessels without lumen mostly (long and short arrows) and the microvascular area was the smallest.
Article Snippet: Tissue sections were stained using
Techniques: Computed Tomography, Immunohistochemical staining, Staining